Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred P Wirth

Showing results (11-20 of 272) with videos related to

Pageof 28
Sort By:
Lancet (London, England)|January 11, 2011
Cabazitaxel for castration-resistant prostate cancerMichael Froehner, Manfred P Wirth
Journal of Comparative Effectiveness Research|October 29, 2014
Approaches to radical prostatectomyMichael Froehner, Manfred P Wirth
Drugs & Aging|October 8, 2013
Locally advanced prostate cancer: optimal therapy in older patientsMichael Froehner, Manfred P Wirth
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Androgen Deprivation Therapy and Alzheimer's DiseaseMichael Froehner, Manfred P Wirth
BJU International|June 26, 2014
Radical prostatectomy at young ageManfred P Wirth, Michael Froehner
European Urology|May 29, 2014
Re: Jim C. Hu, Giorgio Gandaglia, Pierre I. Karakiewicz, et al. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control. Eur Urol 2014;66:666-72Michael Froehner, Manfred P Wirth
European Urology|June 26, 2012
Re: Andrew Vickers, Caroline Bennette, Gunnar Steineck, et al. Individualized estimation of the benefit of radical prostatectomy from the scandinavian prostate cancer group randomized trial. Eur Urol 2012;62:204-9Michael Froehner, Manfred P Wirth
European Urology|March 4, 2016
Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30Michael Froehner, Manfred P Wirth
Drugs & Aging|January 22, 2003
Value of endocrine therapy for early and locally advanced prostate cancerManfred P Wirth, Michael Froehner
Oncology|September 2, 2003
Adjuvant hormonal treatment for prostate cancer: the bicalutamide early prostate cancer programManfred P Wirth, Michael Froehner
Pageof 28

Showing results (11-20 of 272) with videos related to

Sort By:
Pageof 28
Lancet (London, England)|January 11, 2011
Cabazitaxel for castration-resistant prostate cancerMichael Froehner, Manfred P Wirth
Journal of Comparative Effectiveness Research|October 29, 2014
Approaches to radical prostatectomyMichael Froehner, Manfred P Wirth
Drugs & Aging|October 8, 2013
Locally advanced prostate cancer: optimal therapy in older patientsMichael Froehner, Manfred P Wirth
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Androgen Deprivation Therapy and Alzheimer's DiseaseMichael Froehner, Manfred P Wirth
BJU International|June 26, 2014
Radical prostatectomy at young ageManfred P Wirth, Michael Froehner
European Urology|May 29, 2014
Re: Jim C. Hu, Giorgio Gandaglia, Pierre I. Karakiewicz, et al. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control. Eur Urol 2014;66:666-72Michael Froehner, Manfred P Wirth
European Urology|June 26, 2012
Re: Andrew Vickers, Caroline Bennette, Gunnar Steineck, et al. Individualized estimation of the benefit of radical prostatectomy from the scandinavian prostate cancer group randomized trial. Eur Urol 2012;62:204-9Michael Froehner, Manfred P Wirth
European Urology|March 4, 2016
Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30Michael Froehner, Manfred P Wirth
Drugs & Aging|January 22, 2003
Value of endocrine therapy for early and locally advanced prostate cancerManfred P Wirth, Michael Froehner
Oncology|September 2, 2003
Adjuvant hormonal treatment for prostate cancer: the bicalutamide early prostate cancer programManfred P Wirth, Michael Froehner
Pageof 28